Instrument Segment Expected to Hold Significant Cold Laser Therapy Market Share
According to our new research study on "Cold Laser Therapy Market Forecast to 2031 Global Analysis – by Product, Application, and End User,” the market size is expected to grow from US$ 356.33 million in 2024 to US$ 562.62 million by 2031; it is anticipated to record a CAGR of 6.90% during 2025–2031. The report highlights the factors driving the market and the developments of prominent players. Factors such as the rising prevalence of chronic pain conditions, such as musculoskeletal diseases, and technological advancements in devices propel the cold laser therapy market growth. However, a lack of reimbursement and insurance coverage and high treatment costs hinder the growth of the market.
Cold laser therapy, also known as low-level laser therapy (LLLT), is a noninvasive and painless treatment that stimulates the healing process by reducing pain and inflammation in the body using low levels of light. During the therapy, different wavelengths of light are directed at the affected body part. The targeted tissue absorbs light at red and near-infrared wavelengths to promote blood circulation and stimulate healing by regenerating damaged cells.
Cold Laser Therapy Market, by Geography, 2024 (%)
Cold Laser Therapy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments and Accessories), Application (Orthopedics, Dermatology, Neurology, and Others), End User (Hospital, Specialty Clinics, Homecare Settings, and Others)
Cold Laser Therapy Market Insights, Drivers and Growth 2031
Download Free Sample
Source: The Insight Partners Analysis
The development of new and safe laser therapies for clinical indications has led to the growing preference for noninvasive, drug-free treatments such as cold laser therapies for various medical indications. Market players are capitalizing on this trend with targeted product innovations. In April 2024, Domer Technology launched the Class 3B and Class 4 Laser devices. These devices are designed for the precise treatment of joint injuries, offering improved penetration depths. This process allows clinicians to treat osteoarthritis and tendonitis more effectively.
Meanwhile, APEX Medical introduced new pulsed laser systems in May 2024. These systems offer variable wavelengths for customized musculoskeletal protocols, showing up to 40% faster pain relief in clinical tests. Erchonia Corporation received 17 FDA clearances for its FX-635 low-level laser and achieved a 72% success rate in trials for chronic back pain, strengthening its presence in outpatient settings.
The combination of increasing prevalence and innovative product pipelines drives cold laser therapy market growth. It creates solid investment opportunities in research, development, and distribution networks. Strategic partnerships with clinical practices will be crucial to capturing this rapidly growing market. In December 2023, Zolar Technologies partnered with Oral Science to launch a new Zolar Photon EXE, a compact and portable diode laser system. This laser system is designed for dental surgical procedures and LLLT applications.
The availability of FDA-approved cold laser therapy devices and the growing demand for low-intensity laser therapies among physicians and patients have led to the replacement of traditional high-intensity lasers with advanced cold laser therapy to improve patient outcomes.
Cold Laser Therapy Market Analysis Based on Segmental Evaluation:
Based on product, the market is bifurcated into instruments and accessories. The instruments segment held a larger market share in 2024 and is anticipated to register the highest CAGR during 2025–2031. Cold laser devices utilize low-frequency, continuous, or pulsed lasers with a wavelength of 600 to 1000 nm to provide a non-invasive alternative to surgery and acupuncture. It eliminates the complications of long-term drug treatment programs.
By application, the cold laser therapy market is segmented into orthopedics, dermatology, neurology, and others. The orthopedics segment held the largest cold laser therapy market share in 2024.
Per end user, the market is classified into hospitals, specialty clinics, homecare settings, and others. In 2024, the hospital segment held the largest cold laser therapy market share. The specialty clinics segment is anticipated to register the highest CAGR during 2025–2031.
Geographically, the cold laser therapy market report is segmented into North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). In 2024, North America held the largest global market share and is estimated to continue its dominance during the forecast period. The US has a high prevalence of orthopedic diseases and musculoskeletal injuries, which is expected to expand the cold laser therapy market size in the region. With a growing elderly population, the number of musculoskeletal disease cases is likely to rise in the US. The needs of older adults and those with chronic pain and musculoskeletal disorders are increasingly met through cold laser therapy, which includes home-use and clinical options. These treatments enhance seniors' independence and quality of life by helping them manage pain, inflammation, and mobility issues.
The US has a robust regulatory framework, overseen by the FDA, which encourages manufacturers to focus on expanding their product lines to strengthen their market position.
Bioventus LLC, Lumenis Ltd, BTL Industries Inc, Dynatronics Corporation, Zimmer MedizinSysteme GmbH, Theralase Technologies Inc, Erchonia Corporation, Enovis Corp., and Biolase Inc are among the key players profiled in the cold laser therapy market report. The companies implement strategies that contribute to their growth and lead to changes in the market. The companies utilize organic strategies (such as product launches, expansion, and product approvals) and inorganic strategies (such as collaborations and partnerships) to stay competitive in the market.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com